These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6422844

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin.
    Heilesen AM, Permin H, Koch C, Høiby N.
    Scand J Infect Dis; 1983; 15(3):271-6. PubMed ID: 6417770
    [Abstract] [Full Text] [Related]

  • 23. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.
    Smith AL, Fiel SB, Mayer-Hamblett N, Ramsey B, Burns JL.
    Chest; 2003 May; 123(5):1495-502. PubMed ID: 12740266
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams.
    Clark ST, Sinha U, Zhang Y, Wang PW, Donaldson SL, Coburn B, Waters VJ, Yau YCW, Tullis DE, Guttman DS, Hwang DM.
    Int J Antimicrob Agents; 2019 May; 53(5):620-628. PubMed ID: 30664925
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis.
    Smith AL, Ramsey BW, Hedges DL, Hack B, Williams-Warren J, Weber A, Gore EJ, Redding GJ.
    Pediatr Pulmonol; 1989 May; 7(4):265-71. PubMed ID: 2515523
    [Abstract] [Full Text] [Related]

  • 32. [Laboratory and clinical studies on cefsulodin (author's transl)].
    Kumasaka Y, Nakahata H, Endo K, Sasaki K, Matsuhashi A, Narita S, Imamura K, Takebe K, Masaki N, Tamura T.
    Jpn J Antibiot; 1981 Oct; 34(10):1416-21. PubMed ID: 6460884
    [Abstract] [Full Text] [Related]

  • 33. Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis.
    Arguedas AG, Stutman HR, Zaleska M, Knupp CA, Marks MI, Nussbaum E.
    Am J Dis Child; 1992 Jul; 146(7):797-802. PubMed ID: 1496945
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical studies of cefsulodin in the pediatric field].
    Minamitani M, Hachimori K, Suzuki M.
    Jpn J Antibiot; 1982 Nov; 35(11):2676-82. PubMed ID: 7169666
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.